• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Imfinzi (durvalumab)

AZ
Pharma

AZ's Imfinzi keeps MIBC race against Keytruda hot with FDA nod

AstraZeneca has crossed the finish line in MIBC with its own doublet wedding Pfizer and Astellas’ Padcev with its PD-L1 inhibitor Imfinzi.
Fraiser Kansteiner Nov 13, 2026 5:40pm
Xia

Akeso CEO looks for more ivonescimab combos after AZ deal

Oct 25, 2026 11:30am
AZ

ESMO: AstraZeneca pitches own Padcev combos in bladder cancer

Oct 24, 2026 10:30am
Amgen

ESMO: Amgen’s Imdelltra stages Rasonque-like moment in SCLC

Oct 24, 2026 10:30am
Amgen

Amgen’s Imdelltra scores overall survival win in first-line SCLC

Sep 8, 2026 11:42am
checkered flag finish line racecar

FDA expands Padcev-Keytruda combo to more MIBC patients

Jul 10, 2026 1:10pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings